Drugs / iNeo-Vac-T01 Personalized T Cell Injection
iNeo-Vac-T01 Personalized T Cell Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07123545 | Aug 2025 → Jul 2027 expected | hepatocellular carcinoma | Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iNeo-Vac-T01 Personalized T Cell Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07123545 ↗ |
| Modality | Cell therapy | “iNeo-Vac-T01 Personalized Cell Therapy” NCT07123545 ↗ |
| Route | Intravenous | “Administered via intravenous infusion” NCT07123545 ↗ |